| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 7e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |